March 2017

 

In this Supplement

Trust Is Earned

An overview of clinical outcomes and advanced treatment options for endovascular aortic repair.

Issue

Supplement

Download a PDF of this supplement

Trust is Earned: Insights From the 5,000 Patients Enrolled in GREAT

An overview of early data on the outcomes of this multicenter, prospective registry for all commercially available Gore aortic endografts.

By Ross Milner, MD, FACS; and Dennis Gable, MD, RVT, FACS

Preservation Matters

Clinician and patient perspectives from the first bilateral iliac branch endoprosthesis procedure in the United States.

With Sharif H. Ellozy, MD; and John Grieco

Imaging Considerations for Every Endovascular Aortic Branch Program

With increasing case complexity, proper protocol is crucial.

By Gustavo S. Oderich, MD; and Giuliano Sandri, MD

Tested by Time

The story of the evolution of endovascular aneurysm repair and the GORE® EXCLUDER® Device.

By Michael M. McNally, MD; and Scott L. Stevens, MD

Thoracic Branch Endoprosthesis: Early Case Experience and the Clinical Trial

An evaluation of the device’s capabilities and early clinical experience.

By Michael D. Dake, MD; and Himanshu J. Patel, MD

Evolving Endovascular Treatment of Type B Dissection

Two leading centers weigh in on current practice.

With Martyn Knowles, MD; Mark Farber, MD; Robert S. Crawford, MD, FACS; and Bradley S. Taylor, MD, MPH

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.